Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Avacopan

Aliases
AMG 569, CCX168
Name
TAVNEOS
INN Name
avacopan
FDA Approved
Yes

7 clinical trials

1 organization

7 indications

1 document

Indication
Hidradenitis Suppurativa
Indication
Healthy Control Participants
Indication
Liver Impairment
Indication
Electrocardiography
Indication
C3 Glomerulopathy
Indication
Vasculitis
Indication
End-Stage Renal Disease
Clinical trial
A Randomized , Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Completed, Estimated PCD: 2021-01-14
Clinical trial
An Open-Label, Phase 1 Study to Evaluate the Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics of a Single Dose of Simvastatin in Healthy Volunteers
Status: Completed, Estimated PCD: 2022-08-11
Clinical trial
An Open-Label, Phase 1 Study to Evaluate the Single-dose Pharmacokinetics of Avacopan (CCX168) in Male and Female Subjects With Mild or Moderate Hepatic Impairment
Status: Completed, Estimated PCD: 2018-09-18
Clinical trial
A Multiple-dose, Randomized, Double-blind, Placebo-controlled, Active-Comparator, Parallel Study to Investigate the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Subjects
Status: Completed, Estimated PCD: 2020-01-22
Clinical trial
A Randomized, Double Blind, Placebo Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan (CCX168) in Patients With C3 Glomerulopathy
Status: Completed, Estimated PCD: 2021-03-03
Clinical trial
A Phase 3, Open-label, Uncontrolled Single-arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Avacopan in Combination With a Rituximab or a Cyclophosphamide-containing Regimen in Children From 6 Years to < 18 Years of Age With Active ANCA-associated Vasculitis (AAV)
Status: Not yet recruiting, Estimated PCD: 2030-04-28
Clinical trial
A Phase 1, Open-label, Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Avacopan in Subjects With Normal Renal Function and Subjects With End-Stage Renal Disease (ESRD) Requiring Hemodialysis
Status: Not yet recruiting, Estimated PCD: 2025-01-10
Document
DailyMed Label: TAVNEOS
Organization
ChemoCentryx, Inc.